CL vs EMBC · P/E 34, rev $20.38B vs P/E 12, rev $1.08B
Colgate-Palmolive Company (CL) versus Embecta Corp (EMBC) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
CL currently screens at market cap $70.88B and trailing P/E 34.3. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
Not investment advice. Open the CL and EMBC stock pages for the full models.
Not investment advice.